// App-Quantinova.ai

: ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY

Researchers

Presenter

  • Nicholas Nguyen

Principal Investigators

  • Chijioke Ukoha

  • Farukh Ikram

  • Chirag Patel

  • Hao Nguyen

  • Lawrence Hoang

  • Priyanka Acharya

  • Anmol Dhillon

  • Manavjot Sidhu

Medical Centers

  • Methodist Dallas Medical Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

Disease

  • Deep vein thrombosis

  • Myocardial infarction

  • Pulmonary embolism

  • Venous thrombosis

  • Coronavirus disease

  • Stroke

Biomarkers

  • Interleukin 6

Drug/Treatment

  • ILS-969

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved